You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Baseline metabolic tumor volume as a strong predictive and prognostic biomarker in patients with non-small cell lung cancer treated with PD1 inhibitors: a prospective study

Article metrics

Article menu

Download PDFPDF

XML
Immunotherapy biomarkers
Original research
Baseline metabolic tumor volume as a strong predictive and prognostic biomarker in patients with non-small cell lung cancer treated with PD1 inhibitors: a prospective study

 

Online download statistics by month:

Online download statistics by month: July 2020 to February 2026

AbstractFullPdf
Jul 202025425462
Aug 2020226227113
Sep 2020636328
Oct 2020636341
Nov 2020393918
Dec 202026269
Jan 2021525249
Feb 2021515113
Mar 2021525239
Apr 2021606025
May 2021454517
Jun 2021373714
Jul 2021313111
Aug 2021343414
Sep 2021434328
Oct 2021474726
Nov 2021484842
Dec 2021343512
Jan 2022373911
Feb 202226268
Mar 2022454736
Apr 2022414531
May 2022454821
Jun 2022495020
Jul 2022353716
Aug 2022454533
Sep 2022525243
Oct 2022394117
Nov 2022353612
Dec 2022565712
Jan 2023565818
Feb 2023969823
Mar 2023545722
Apr 2023242618
May 2023414216
Jun 2023363624
Jul 2023323321
Aug 2023293021
Sep 202316179
Oct 2023303017
Nov 202342428
Dec 202311811812
Jan 2024242543
Feb 2024404117
Mar 2024646755
Apr 2024545632
May 2024353521
Jun 202442439
Jul 2024626524
Aug 202416164
Sep 202420237
Oct 2024323215
Nov 2024383911
Dec 2024505016
Jan 2025394010
Feb 2025474817
Mar 2025515417
Apr 2025727620
May 2025343416
Jun 2025464714
Jul 2025110
Sep 2025110
Feb 2026110
Total305331111378